Paper3142256
The immunohistology of IgA nephropathy.
Jennette JC. Am J Kidney Dis, 1988. Cited by 137 papers, by iCite.
Cite this record
ConductScience Library. The immunohistology of IgA nephropathy. Papers, record 3142256. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3142256
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glomerulonephritis, IGA | Major topic |
| Kidney | Major topic |
| Biopsy | |
| Complement System Proteins | |
| Diagnosis, Differential | |
| Humans | |
| Immunoglobulin Light Chains | |
| Immunohistochemistry |
Source PubMed
Cited by68
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 137 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42183202 | The role of mucosal immune dysregulation in the pathogenesis of immunoglobulin A nephropathy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42183202 | PubMed |
| 42146603 | Inhibition of p65 NF-κB enhances production of galactose-deficient IgA1 through suppression of C1GALT1 and SP1 in plasmablast-like cell subpopulations. | bioRxiv | 2026 | https://conductscience.org/library/papers/42146603 | PubMed |
| 41878430 | Autoimmunity in IgA nephropathy. | Front Immunol | 2026 | https://conductscience.org/library/papers/41878430 | PubMed |
| 40992572 | Kidney injury and colocalization of complement C3, IgA, and IgG in glomerular immune-complex deposits of patients with IgA nephropathy or IgA vasculitis with nephritis. | Kidney Int | 2025 | https://conductscience.org/library/papers/40992572 | PubMed |
| 40087124 | Emerging Biochemical and Immunologic Mechanisms in the Pathogenesis of IgA Nephropathy. | Semin Nephrol | 2024 | https://conductscience.org/library/papers/40087124 | PubMed |
| 39678627 | Immunofluorescence Use and Techniques in Glomerular Diseases: A Review. | Glomerular Dis | 2024 | https://conductscience.org/library/papers/39678627 | PubMed |
| 39639420 | Characteristics of glomerulonephritis with dominant C1q precipitation compared to corresponding glomerulonephritis without C1q staining on immunofluorescent examination. | Kidney Res Clin Pract | 2025 | https://conductscience.org/library/papers/39639420 | PubMed |
| 39156850 | IgA Nephropathy: Emerging Mechanisms of Disease. | Indian J Nephrol | 2024 | https://conductscience.org/library/papers/39156850 | PubMed |
| 38731122 | C3 Hypocomplementemia Predicts the Progression of CKD towards End-Stage Kidney Disease in IgA Nephropathy, Irrespective of Histological Evidence of Thrombotic Microangiopathy. | J Clin Med | 2024 | https://conductscience.org/library/papers/38731122 | PubMed |
| 38254967 | Liquid Biopsy: A New Avenue for the Diagnosis of Kidney Disease: Diabetic Kidney Disease, Renal Cancer, and IgA Nephropathy. | Genes (Basel) | 2024 | https://conductscience.org/library/papers/38254967 | PubMed |
| 37747686 | Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy. | Drugs | 2023 | https://conductscience.org/library/papers/37747686 | PubMed |
| 37637870 | Knowledge Translation in Glomerulonephritis: Successes in Translational Research From the Bench to Bedside. | Can J Kidney Health Dis | 2023 | https://conductscience.org/library/papers/37637870 | PubMed |
| 36865536 | IgA Nephropathy: Pleiotropic impact of Epstein-Barr virus infection on immunopathogenesis and racial incidence of the disease. | Front Immunol | 2023 | https://conductscience.org/library/papers/36865536 | PubMed |
| 36849627 | The significance of galactose-deficient immunoglobulin A1 staining in kidney diseases with IgA deposition. | Int Urol Nephrol | 2023 | https://conductscience.org/library/papers/36849627 | PubMed |
| 36751266 | IgA Nephropathy: A Chinese Perspective. | Glomerular Dis | 2022 | https://conductscience.org/library/papers/36751266 | PubMed |
| 36531879 | Clinicopathologic Significance of Predominant Lambda Light Chain Deposition in IgA Nephropathy. | Kidney Int Rep | 2022 | https://conductscience.org/library/papers/36531879 | PubMed |
| 36306365 | Identification and characterization of circulating immune complexes in IgA nephropathy. | Sci Adv | 2022 | https://conductscience.org/library/papers/36306365 | PubMed |
| 36245664 | The Gut and Kidney Crosstalk in Immunoglobulin A Nephropathy. | Kidney360 | 2022 | https://conductscience.org/library/papers/36245664 | PubMed |
| 35955995 | Special Issue: New Insights into the Pathogenesis and Therapies of IgA Nephropathy. | J Clin Med | 2022 | https://conductscience.org/library/papers/35955995 | PubMed |
| 35916957 | How to take advantage of easily available biomarkers in patients with IgA nephropathy: IgA and C3 in serum and kidney biopsies. | Pediatr Nephrol | 2023 | https://conductscience.org/library/papers/35916957 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| C1QA | 712 | PubTator's text mining | https://conductscience.org/library/genes/712 | NCBI Gene |
| CD79A | 973 | PubTator's text mining | https://conductscience.org/library/genes/973 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3142256
GET https://conductscience.org/api/papers/v1/3142256/cited_by?page=2